When using TOCSY NMR for enantiodifferentiation with amino acids as chiral ligands, it is essential to design well-controlled experiments. This may involve testing various amino acids, optimizing experimental conditions, and comparing the results to a reference compound or standard.
If you need to purchase chemical raw materials, submit your demand information to get the latest quotations.
C27H48N6O3
4-(isothiocyanatomethyl)benzenesulfonamide
methyl 2-[4-methoxy-4-(triethylsilylperoxy)cyclohexyl]acetate
sodium 1-O-octadecyl-2-(6-(all-trans-retinoyloxy)hexanoyl)-sn-glycero-3-phospho-(S)-glycerol
pent-4-enyl 2-azido 4,6-O-benzylidene 2-deoxy-3-O-(methyl 2,3,4-tri-O-acetyl β-D-glucopyranosyluronate)-β-D-glucopyranoside
methylmalononitrile anion
C14H19BBr2O2
N-(6-(1H-indol-4-yl)-1H-indazol-4-yl)benzamide
4-bromo-N-ethyl-3-(trifluoromethyl)benzenesulfonamide
2-<(4-methylphenyl)methyl>phenylacetic acid
Benzoic acid, 5-[[[[[[4-(1,1-dimethylethyl)phenyl]methyl]amino]thioxomethyl]amino]meth yl]-2-[(methylsulfonyl)amino]-, methyl ester
[1S,4R,5R,6S,8R(2'S)]-8-(2'-benzyloxy-3'-oxobutyl)-4-isopropyl-1-methyl-6-methoxy-7-oxabicyclo[3.2.1]octane
1,3,5-tris(cyanomethyl)-2,4,6-triethylbenzene
1,3-Propanediamine, N-(triphenylmethyl)-N'-[3-[(triphenylmethyl)amino]propyl]-
5-O-benzyl-3-deoxy-D-glycero-2-pentulose
3-DIMETHYLAMINO-2,2-DIMETHYL-1-PROPANOL
(2S,RS)-2-<<(4-methylphenyl)sulphinyl>methyl>-2-(trifluoromethyl)oxirane
2-(4-chlorophenyl)-3-(2-nitrophenyl)prop-2-enoic acid
p-nitrophenyl-α-D-glucopyranosyl-(1→4)-O-α-D-glucopyranoside
acetamide, N-(4-tricyclo[3.3.1.1~3,7~]dec-1-ylphenyl)-
METHYL FORMATE-D
methyl 2-[(diethoxyphosphoryl)difluoromethyl]-5-iodobenzoate
Nicotinonitrile, 1,4-dihydro-4-oxo- (6CI)
2,6-dimethyl-4-phenyl-1,4-dihydropyridine-3,5-dicarboxylic acid 5-bis[2-(aminothioxomethyl)hydrazide]
N2-(p-fluorophenyl)-9-β-D-ribofuranosylguanine 5'-triphosphate
N-benzyl-2,3,4,9-tetrahydro-1H-carbazol-1-amine
(Z)-Methyl 4,6-O-isopropylidene-7-C-phenyl-L-ido-hept-2-enonate
allyl-3-O-allyl-4,6-O-benzylidene-α-D-glucopyranoside
N-[2-(1H-imidazol-1-yl)-1-phenylethylidene]-N'-phenylhydrazine
(CARBOETHOXYMETHYL)TRIPHENYLPHOSPHONIUM CHLORIDE HYDRATE
Toluene-4-sulfonic acid (1S,6S,7R)-1-methyl-5-oxo-bicyclo[4.3.1]dec-7-yl ester
1,2,3-triphenyl-3-formylcyclopropene
13-acetoxy-13-desmethylretinal 15,15-dimethyl acetal
(5Z)-5-(1H-INDOL-3-YLMETHYLENE)IMIDAZOLIDINE-2,4-DIONE
2(5H)-Furanone, 5-ethoxy-3-[(S)-(4-methylphenyl)sulfinyl]-, (5S)-
(2E)-N-(1-hydroxy-2-methylpropan-2-yl)-3-phenylprop-2-enamide
tert-Butyl ((3R,5S)-rel-5-methylpiperidin-3-yl)carbamate
C25H34N6O3
benzyl (S)-2-((S)-1-((S)-2-((tert-butoxycarbonyl)amino)-2-cyclohexylacetyl)pyrrolidine-2-carboxamido)-3,3-diphenylpropanoate
4-ETHYL-2-PHENYL-1H-IMIDAZOLE
2,6-Piperidinedione, 1-(phenylmethoxy)-
Glycine, N-[N-[N-[(1,1-dimethylethoxy)carbonyl]-L-tyrosyl]-2-methylalanyl]-, methyl ester
C18H19N5O3
diethyl 2-[cyano(toluene-4-sulfinyl)methylene]propanedioate
N-(3-chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)methanesulfonamide
